Dennis M Klinman Selected Research

Lung Neoplasms (Lung Cancer)

1/2018	Silicosis and lung cancer: current perspectives.
5/2014	Suppressive oligodeoxynucleotides reduce lung cancer susceptibility in mice with silicosis.
2/2013	Suppressive oligodeoxynucleotides synergistically enhance antiproliferative effects of anticancer drugs in A549 human lung cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dennis M Klinman Research Topics

Disease

32	Neoplasms (Cancer) 01/2023 - 09/2002
17	Inflammation (Inflammations) 01/2022 - 08/2002
16	Infections 12/2019 - 06/2002
9	Communicable Diseases (Infectious Diseases) 01/2021 - 09/2002
8	Pneumonia (Pneumonitis) 09/2016 - 11/2002
6	Autoimmune Diseases (Autoimmune Disease) 12/2014 - 10/2004
6	Anthrax 12/2009 - 07/2004
4	Hypersensitivity (Allergy) 01/2021 - 10/2003
3	Lung Neoplasms (Lung Cancer) 01/2018 - 02/2013
3	Lung Injury 09/2016 - 10/2004
3	Virus Diseases (Viral Diseases) 08/2012 - 03/2003
2	Neoplasm Metastasis (Metastasis) 01/2023 - 05/2011
2	Carcinogenesis 01/2022 - 05/2011
2	Sepsis (Septicemia) 01/2020 - 05/2008
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2018 - 06/2012
2	Glomerulonephritis 09/2014 - 02/2005
2	Silicosis 05/2014 - 06/2008
2	Wounds and Injuries (Trauma) 06/2011 - 11/2010
2	Shock 05/2011 - 04/2005
2	Asthma (Bronchial Asthma) 10/2003 - 11/2002
2	Arthritis (Polyarthritis) 06/2003 - 08/2002
2	Leishmaniasis 05/2003 - 02/2002
1	Breast Neoplasms (Breast Cancer) 01/2023
1	Melanoma (Melanoma, Malignant) 01/2022
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2022
1	Emphysema 01/2022
1	Bites and Stings (Sting) 01/2021
1	Proteinuria 01/2019
1	Disease Progression 01/2019
1	Colonic Neoplasms (Colon Cancer) 01/2018
1	Colitis 09/2017
1	Lupus Nephritis 01/2017
1	Critical Illness (Critically Ill) 09/2016
1	Ventilator-Induced Lung Injury 09/2016
1	Septic Shock (Toxic Shock Syndrome) 03/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2015
1	Brain Injuries (Brain Injury) 01/2015

Drug/Important Bio-Agent (IBA)

30	CPG-oligonucleotideIBA 01/2021 - 02/2002
26	OligodeoxyribonucleotidesIBA 01/2018 - 06/2002
16	OligonucleotidesIBA 01/2022 - 05/2004
16	VaccinesIBA 01/2021 - 01/2004
14	CytokinesIBA 01/2022 - 11/2002
9	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 06/2002
7	Vaccine AdjuvantsIBA 01/2016 - 06/2002
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2002
6	AntigensIBA 01/2014 - 06/2002
5	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2023 - 07/2006
4	Toll-Like Receptor 9IBA 01/2018 - 08/2005
4	LigandsIBA 01/2018 - 11/2006
4	ChemokinesIBA 05/2011 - 06/2004
3	SmokeIBA 01/2022 - 05/2014
3	InflammasomesIBA 01/2022 - 01/2015
3	InterferonsIBA 01/2021 - 01/2015
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 03/2009
3	Silicon Dioxide (Silica)FDA LinkGeneric 01/2018 - 06/2008
3	AllergensIBA 04/2004 - 07/2003
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023 - 01/2017
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2015
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2018
2	Pattern Recognition ReceptorsIBA 01/2022 - 01/2022
2	Oxygen (Dioxygen)IBA 01/2020 - 01/2015
2	Toll-Like Receptor AgonistsIBA 12/2019 - 05/2015
2	CarcinogensIBA 01/2018 - 05/2014
2	InterleukinsIBA 01/2015 - 01/2011
2	Cancer VaccinesIBA 01/2014 - 05/2011
2	Recombinant ProteinsIBA 04/2007 - 06/2002
2	Interleukin-12 (IL 12)IBA 11/2006 - 11/2002
2	Immunoglobulin G (IgG)IBA 10/2006 - 02/2005
2	DNA VaccinesIBA 09/2006 - 07/2006
2	Anthrax Vaccines (Vaccines, Anthrax)IBA 06/2006 - 07/2004
2	Bacterial DNAIBA 12/2003 - 08/2002
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2003 - 03/2003
1	LuciferasesIBA 01/2023
1	Interleukin-18 (Interleukin 18)IBA 01/2022
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2022
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2022
1	Interferon Type IIBA 01/2021
1	Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA 01/2021
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2021
1	DNA receptor (receptor, DNA)IBA 01/2021
1	Oncogene Proteins (Oncogene Protein)IBA 01/2020
1	AutoantibodiesIBA 01/2019
1	Type II Tumor Necrosis Factor ReceptorsIBA 01/2018
1	Synthetic Vaccines (Recombinant Vaccines)IBA 12/2017
1	Evans Blue (Blue, Evans)FDA Link 12/2017
1	AlbuminsIBA 12/2017
1	Albumin-Bound Paclitaxel FDA Link 12/2017
1	Subunit VaccinesIBA 12/2017
1	Dextran SulfateIBA 09/2017
1	LipopolysaccharidesIBA 09/2017
1	hen egg lysozymeIBA 01/2017
1	Interleukin-4 (Interleukin 4)IBA 01/2017
1	Methylprednisolone FDA LinkGeneric 01/2017
1	AutoantigensIBA 01/2017
1	Phosphotransferases (Kinase)IBA 01/2015

Therapy/Procedure

12	Therapeutics 01/2023 - 12/2003
12	Immunotherapy 01/2020 - 09/2002
1	Mechanical Ventilators (Ventilator) 09/2016
1	General Anesthesia 09/2016
1	Artificial Respiration (Mechanical Ventilation) 09/2016